We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$60.5B
AUM Growth
+$2.39B
Cap. Flow
+$1.77B
Cap. Flow %
2.93%
Top 10 Hldgs %
17.56%
Holding
4,827
New
882
Increased
1,455
Reduced
1,567
Closed
849

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$210M
2
UNH icon
UnitedHealth
UNH
+$158M
3
NFLX icon
Netflix
NFLX
+$140M
4
DG icon
Dollar General
DG
+$135M
5
MU icon
Micron Technology
MU
+$124M

Sector Composition

Rank Sector Weight
1 Technology 9.07%
2 Consumer Discretionary 6.01%
3 Healthcare 4.63%
4 Industrials 4.29%
5 Financials 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPCR icon
2976
Structure Therapeutics
GPCR
$3.4B
$567K ﹤0.01%
14,449
+617
+4% +$25.3K
EIX icon
2977
PUT
Edison International
EIX
$30.7B
$567K ﹤0.01%
7,900
-7,100
-47% -$515K
VTOL icon
2978
Bristow Group
VTOL
$1.34B
$567K ﹤0.01%
16,901
+6,806
+67% +$211K
GH icon
2979
Guardant Health
GH
$19B
$566K ﹤0.01%
19,592
-695,720
-97% -$16.2M
FHI icon
2980
Federated Hermes
FHI
$4.59B
$566K ﹤0.01%
17,202
-118,171
-87% -$3.96M
FUL icon
2981
H.B. Fuller
FUL
$3.07B
$565K ﹤0.01%
7,335
+3,288
+81% +$256K
MXCT icon
2982
MaxCyte
MXCT
$112M
$564K ﹤0.01%
143,989
-25,153
-15% -$108K
VTR icon
2983
Ventas
VTR
$47.7B
$562K ﹤0.01%
10,970
-18,359
-63% -$860K
AXTI icon
2984
AXT Inc
AXTI
$2.8B
$561K ﹤0.01%
166,072
+111,934
+207% +$391K
BPMC
2985
CALL
DELISTED
Blueprint Medicines
BPMC
$560K ﹤0.01%
5,200
-4,600
-47% -$460K
DRI icon
2986
PUT
Darden Restaurants
DRI
$23.7B
$560K ﹤0.01%
+3,700
New +$563K
CPAY icon
2987
CALL
Corpay
CPAY
$25.1B
$559K ﹤0.01%
2,100
-1,000
-32% -$283K
EVRG icon
2988
Evergy
EVRG
$19.7B
$559K ﹤0.01%
10,558
-61,767
-85% -$3.29M
BAX icon
2989
PUT
Baxter International
BAX
$12.6B
$559K ﹤0.01%
16,700
-143,300
-90% -$5.28M
VRTS icon
2990
Virtus Investment Partners
VRTS
$1.14B
$556K ﹤0.01%
2,461
+668
+37% +$152K
WH icon
2991
Wyndham Hotels & Resorts
WH
$5.62B
$555K ﹤0.01%
7,502
-14,631
-66% -$1.05M
AIV
2992
Aimco
AIV
$375M
$553K ﹤0.01%
66,698
-4,041
-6% -$32.6K
PPL
2993
PPL Corp
PPL
$27.3B
$553K ﹤0.01%
19,992
+2
+0% +$56
LIND icon
2994
Lindblad Expeditions
LIND
$1.95B
$552K ﹤0.01%
57,221
-32,437
-36% -$251K
PRAX icon
2995
Praxis Precision Medicines
PRAX
$8.25B
$552K ﹤0.01%
13,348
+6,942
+108% +$328K
GTX icon
2996
Garrett Motion
GTX
$5.6B
$552K ﹤0.01%
+64,254
New +$593K
CGNT icon
2997
CALL
Cognyte Software
CGNT
$657M
$550K ﹤0.01%
72,000
MLTX icon
2998
CALL
MoonLake Immunotherapeutics
MLTX
$1.59B
$550K ﹤0.01%
+12,500
New +$529K
MLTX icon
2999
PUT
MoonLake Immunotherapeutics
MLTX
$1.59B
$550K ﹤0.01%
+12,500
New +$529K
EWBC icon
3000
CALL
East-West Bancorp
EWBC
$18B
$549K ﹤0.01%
+7,500
New +$556K

Similar funds

Squarepoint's Q2 2024 Portfolio in Review

As of Q2 2024, Squarepoint held 4,827 positions worth $60.5B, up 4.1% from $58.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Squarepoint's Q2 2024 filing shows 882 new, 1,455 increased, 1,567 reduced and 849 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M. The largest sale was Apple, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Squarepoint's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M.
  • Squarepoint added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.29B increase.
  • Squarepoint's biggest Q2 2024 reduction was Apple, cutting an estimated $210M.
  • Squarepoint fully exited DraftKings in Q2 2024, selling an estimated $94.6M.
  • Squarepoint's ten largest holdings make up 18% of its $60.5B portfolio in Q2 2024.
  • Squarepoint opened 882 new positions and closed 849 in Q2 2024.
  • Squarepoint's portfolio value rose 4.1% quarter-over-quarter to $60.5B.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.